BNGO
Bionano Genomics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.20
−3.23%Margins
Gross margin
47.5%
EBITDA margin
-74.3%
EBIT margin
-106.7%
Net margin
-106.6%
FCF margin
-67.9%
-101.8%
Return on equity
-67.6%
Return on assets
-84.0%
Return on invested capital
0.54x
Asset turnover
-$20.5M
Cash from operations
$0.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026